These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8482808)

  • 1. Aging and the pharmacokinetics and metabolism of metoprolol enantiomers in the rat.
    Vermeulen AM; Belpaire FM; De Smet F; Vercruysse I; Bogaert MG
    J Gerontol; 1993 May; 48(3):B108-14. PubMed ID: 8482808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age on stereoselective pharmacokinetics and metabolism of hexobarbital in the rat.
    Vermeulen AM; Belpaire FM; De Smet F; Rosseel MT; Bogaert MG
    Mech Ageing Dev; 1992 Sep; 65(2-3):167-75. PubMed ID: 1434946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective pharmacokinetics of atenolol in the rat: influence of aging and of renal failure.
    Belpaire FM; Rosseel MT; Vermeulen AM; De Smet F; Bogaert MG
    Mech Ageing Dev; 1993 Feb; 67(1-2):201-10. PubMed ID: 8469031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of metoprolol enantiomers following single and multiple administration of racemate in rat.
    Mostafavi SA; Foster RT
    Int J Pharm; 2000 Jul; 202(1-2):97-102. PubMed ID: 10915931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
    Cerqueira PM; Cesarino EJ; Mateus FH; Mere Y; Santos SR; Lanchote VL
    Chirality; 1999; 11(7):591-7. PubMed ID: 10423287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects.
    Murthy SS; Nelson WL; Shen DD; Power JM; Cahill CM; McLean AJ
    Drug Metab Dispos; 1991; 19(6):1093-100. PubMed ID: 1687016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacokinetics of Metoprolol: A Systematic Review.
    Zamir A; Hussain I; Ur Rehman A; Ashraf W; Imran I; Saeed H; Majeed A; Alqahtani F; Rasool MF
    Clin Pharmacokinet; 2022 Aug; 61(8):1095-1114. PubMed ID: 35764772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective metabolism of metoprolol in isolated rat liver.
    Chen XX; Zhang YD; Shen JP
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):440-2. PubMed ID: 10375805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic differences between pantoprazole enantiomers in rats.
    Xie Z; Zhang Y; Xu H; Zhong D
    Pharm Res; 2005 Oct; 22(10):1678-84. PubMed ID: 16180125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
    Belpaire FM; de Smet F; Chindavijak B; Fraeyman N; Bogaert MG
    Fundam Clin Pharmacol; 1989; 3(2):79-88. PubMed ID: 2722116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of aging on the stereoselective pharmacokinetics of propranolol in the rat.
    Vermeulen AM; Belpaire FM; Moerman E; de Smet F; Bogaert MG
    Chirality; 1992; 4(2):73-9. PubMed ID: 1616826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition.
    Athukuri BL; Neerati P
    Drug Metab Pers Ther; 2016 Dec; 31(4):229-234. PubMed ID: 27875319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
    Bramer SL; Suri A
    Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of stereoselective pharmacokinetics in the development and predictability of an IVIVC for the enantiomers of metoprolol tartrate.
    Sirisuth N; Eddington ND
    Pharm Res; 2000 Aug; 17(8):1019-25. PubMed ID: 11028951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faster non-renal clearance of metoprolol in streptozotocin-induced diabetes mellitus rats.
    Lee U; Lee I; Lee BK; Kang HE
    Eur J Pharm Sci; 2013 Nov; 50(3-4):447-53. PubMed ID: 23985694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.
    Jonkers RE; Koopmans RP; Portier EJ; van Boxtel CJ
    J Pharmacol Exp Ther; 1991 Mar; 256(3):959-66. PubMed ID: 1848636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
    Cook CS; Karim A; Sollman P
    Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.